Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MICRO MEDICAL SOLUTIONS via INVARIANT LLC
2026 · third_quarter · Q3
Educate policymakers about new technologies for treating patients with advanced vascular disease.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Source: Senate LDA
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, Veterans Affairs, Dept of (VA)
MICRO MEDICAL SOLUTIONS via INVARIANT LLC
2026 · second_quarter · Q2
Educate policymakers about new technologies for treating patients with advanced vascular disease.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, Veterans Affairs, Dept of (VA)
2026 · first_quarter · Q1
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, Veterans Affairs, Dept of (VA)